APA (7th ed.) Citation

J, M., N, H., T, Y., T, Y., H, S., M, S., . . . N, U. (2026). Phase I studies assessing safety and pharmacokinetics of nacubactam administered alone or in combination with cefepime or aztreonam in Japanese healthy participants. Antimicrobial agents and chemotherapy, 70(5), e0177025. https://doi.org/10.1128/aac.01770-25

Chicago Style (17th ed.) Citation

J, Morita, Hida N, Yonemura T, Yamazaki T, Sato H, Sumiya M, Takaya R, Kumagai Y, and Uchida N. "Phase I Studies Assessing Safety and Pharmacokinetics of Nacubactam Administered Alone or in Combination with Cefepime or Aztreonam in Japanese Healthy Participants." Antimicrobial Agents and Chemotherapy 70, no. 5 (2026): e0177025. https://doi.org/10.1128/aac.01770-25.

MLA (9th ed.) Citation

J, Morita, et al. "Phase I Studies Assessing Safety and Pharmacokinetics of Nacubactam Administered Alone or in Combination with Cefepime or Aztreonam in Japanese Healthy Participants." Antimicrobial Agents and Chemotherapy, vol. 70, no. 5, 2026, p. e0177025, https://doi.org/10.1128/aac.01770-25.